Tracing the Leadership Transition: The Ninth Vice-Chancellor Dennis Lo Takes Office and "Governance by Scientist" (2025– )
One-line summary: On 27 September 2024, CUHK's Council unanimously approved the appointment; on 8 January 2025, Dennis Lo — the "father of non-invasive prenatal testing" — succeeded Rocky S. Tuan as the Chinese University of Hong Kong's ninth Vice-Chancellor and President for a five-year term, opening what this article describes as "governance by scientist."
⚠️ This article belongs to the campus-history overview module (00) and records a routine change of leadership based mainly on official announcements. Dennis Lo is the incumbent Vice-Chancellor and is named here under official terminology, in a neutral, non-contentious context. The departure of his predecessor, Rocky S. Tuan, involved public discussion at the level of university governance; this article sets out the publicly stated positions of the parties concerned side by side, without adjudicating between them. Matters touching on the broader political context are presented only as external source links (see Module 18) and are outside the scope of this article's narrative.
A scientist who spent nearly three decades in the laboratory, and who rewrote global prenatal diagnostics with a single tube of a pregnant woman's blood, walked into the top-floor office of the university's administration building in the first week of 2025. He did not rise through the conventional administrative ladder of "academic — dean — deputy vice-chancellor — vice-chancellor," nor had he previously held the university's most senior deputy administrative post; what carried him to the ninth Vice-Chancellorship was three decades of consistent research weight, together with a nearly year-long global search conducted by CUHK. This article traces the transition chronologically: how it happened, who Dennis Lo is, the continuities and differences between him and his predecessor Rocky S. Tuan, and the five-year blueprint he has set out for CUHK.
How Did This Transition Happen? — Nearly a Year of Selection Timeline
The selection of CUHK's ninth Vice-Chancellor followed a documented procedure. According to a university announcement, the Search Committee was formed in February 2024※, followed by four consultation sessions in April to gather views from the university community, and a global search conducted with the assistance of a search-consultancy firm. After the president-designate met with stakeholders on 25–26 September, the Council made its final decision.
The decision itself came on 27 September 2024. According to Xinhua, the CUHK Council that day unanimously approved the appointment of Dennis Lo※ as the ninth Vice-Chancellor for a five-year term, effective from 8 January 2025. The phrase "unanimously approved" stands in contrast to the atmosphere of internal discussion that accompanied his predecessor's own appointment — this was an appointment with little suspense attached to it.
The two ends of the handover were tightly joined. The eighth Vice-Chancellor, Rocky S. Tuan, stepped down on 7 January 2025, and Dennis Lo formally took office the very next day, 8 January, leaving no administrative gap. On his first day, Lo issued an open letter to the university community, describing it as an address on "day one of the term of the incoming Vice-Chancellor and Provost." Its language emphasised continuity: he said he would continue to strengthen the university's strengths "on the foundations laid by his predecessors."
The table below lines up the key points on this timeline, to make the pace and tenor of the whole selection process clear at a glance.
| Date | Event | Attribution/Source |
|---|---|---|
| 9 January 2024 | Predecessor Rocky S. Tuan tendered his resignation to the Council, stepping down two years early | Confirmed by the university |
| February 2024 | Vice-Chancellor Search Committee formed | University announcement |
| April 2024 | Four internal consultation sessions held | University announcement |
| 25–26 September 2024 | President-designate met with stakeholders | University announcement |
| 27 September 2024 | Council unanimously approved the appointment of Dennis Lo for a five-year term | Xinhua |
| 7 January 2025 | Rocky S. Tuan stepped down as eighth Vice-Chancellor | Chinese Wikipedia |
| 8 January 2025 | Dennis Lo formally took office as ninth Vice-Chancellor, issued open letter | CUHK-Shenzhen (official) |
The open letter on the first day set the tone of the transition around two words: "continuity" and "communication." According to the university, Lo pledged in the letter to lead with an attitude of "open communication," to let the whole community draw on "collective wisdom" to guide the university forward, and to place the university's vision on a continued path toward "building a sustainable and more equitable society." The wording was restrained, with little grand rhetoric — consistent with his habitually low-key style as a scientist, and echoing the stable expectations that came with the "unanimous approval." There was no dramatic turn, only the smooth handover of the mantle to a long-serving member of the CUHK community.
Who Is Dennis Lo? — From Cambridge and Oxford to a Tube of Blood in CUHK Chemical Pathology
To understand the weight carried by the phrase "governance by scientist," one must first look at the scientist's own background. According to the English Wikipedia, Dennis Lo was born in Hong Kong in October 1963※; after secondary school he went to the United Kingdom for further study, first reading pre-clinical medicine at Cambridge and then completing clinical training at Oxford, obtaining his medical degree in 1989, a Doctor of Philosophy (DPhil) in 1994, and subsequently a Doctor of Medicine (DM) from Oxford in 2001. He joined the Chinese University of Hong Kong in January 1997※ with the title of Senior Lecturer in Chemical Pathology — a starting point that appeared far removed from "Vice-Chancellor," yet it also meant that nearly three decades of his subsequent academic career grew almost entirely on CUHK soil.
What placed his name in medical history was a discovery made that same year, 1997. Lo demonstrated the presence of cell-free fetal DNA in maternal plasma, publishing the finding in the internationally authoritative medical journal The Lancet. The discovery gave rise to non-invasive prenatal testing (NIPT): a simple blood draw from a pregnant woman can screen for chromosomal conditions such as Down syndrome, without the miscarriage risk associated with invasive procedures such as amniocentesis. He is accordingly known as "the father of non-invasive prenatal testing."
The scale at which this discovery has been put into practice is the best illustration of the phrase "research must reach application." According to mainland media reports, since NIPT entered clinical use around 2011 it has become widely used in more than ninety countries worldwide※, benefiting millions of pregnant women each year and regarded as one of the most widely used prenatal fetal genetic tests globally; on the mainland alone, more than a million pregnant women undergo the test each year. A scientist's single paper eventually became routine practice in obstetric clinics — precisely the model of "translation" that Lo has repeatedly emphasised since.
The technology later moved beyond obstetrics as well. According to official biographical material, Lo currently serves as Director of the Li Ka Shing Institute of Health Sciences at CUHK, Li Ka Shing Professor of Medicine, and Professor of Chemical Pathology; in recent years his team has further applied cell-free DNA sequencing technology to early cancer detection, becoming one of the global founders of the "liquid biopsy" field. From maternal blood to cancer screening, he has consistently done the same thing: reading, in a single tube of blood, information others cannot.
One detail that illustrates his scholarly attitude: according to media reports, Lo has repeatedly stressed that "without basic research, applied technology cannot be produced" — he does not set "application" against "basic research," but treats them as two ends of the same chain. In an April 2025 Xinhua interview, Lo summed up his core research conviction in a single sentence: "Research must be translated into practice, to bring benefit to society." That plain statement was later carried, almost verbatim, into his governing agenda.
What Qualifies a Scientist to Lead a University? — The Academic Weight of Accumulated Honours
At CUHK, the selection of a Vice-Chancellor has never rested on administrative credentials alone, but also on whether the candidate can bring international prestige to the university. According to university announcements and the English Wikipedia, Lo's sequence of honours forms a long timeline; the table below sets out a selection of them.
| Year | Honour | Significance |
|---|---|---|
| 2011 | Elected Fellow of the Royal Society | One of the most senior scientific academies in the English-speaking world |
| 2013 | Elected Foreign Associate of the U.S. National Academy of Sciences | The highest honour system in American science |
| 2016 | Received the Future Science Prize, Life Science Prize | A major prize within the Chinese-speaking scientific community |
| 2021 | Received the Breakthrough Prize in Life Sciences | One of the highest single-award-value science prizes in the world |
| 2021 | Received the Royal Medal of the Royal Society | The Royal Society's highest annual honour |
| 2022 | Received the Lasker Award for Clinical Medical Research | Often described as a "bellwether for the Nobel Prize" |
| 2023 | Elected Academician of the Chinese Academy of Sciences | The highest academic title in mainland Chinese science |
According to a university announcement, Lo is the first ethnic Chinese scientist to receive the Royal Society's biological sciences medal※. The reasoning given by the Council Chairman in the appointment announcement rested precisely on this academic prestige — he stated: "Professor Dennis Lo's outstanding academic achievements have earned him a distinguished international reputation."
Two items on this list carry particular weight. The 2021 Breakthrough Prize, funded by figures from the Silicon Valley technology industry, carries a single-award value of several million U.S. dollars and is among the highest-value science prizes today; the 2022 Lasker Award for Clinical Medical Research is, within the field, often called a "bellwether for the Nobel Prize" — many Lasker laureates have gone on to win the Nobel Prize, which has repeatedly prompted outside discussion of whether Lo might go on to win a Nobel Prize as well※. According to media reports, he himself takes this "in stride," being more concerned with whether the technology benefits patients.
This chain of honours explains the logic behind the "unanimous approval." When a candidate holds fellowships or academician titles from the Royal Society, the U.S. National Academy of Sciences, and the Chinese Academy of Sciences, and has also collected both the Breakthrough Prize and the Lasker Award, the scales of selection scarcely need to hesitate. What CUHK chose was to let the personal brand of a world-class scientist underwrite the university's next five years — the other side of "governance by scientist": the Vice-Chancellor himself is the university's best calling card.
What Did His Predecessor Leave Behind? — The Handover Between Two Scientist Vice-Chancellors
Lo is not CUHK's first Vice-Chancellor to come from a scientific background. His predecessor, Rocky S. Tuan, was likewise a scientist with decades of standing in the international academic community, making the handover more a case of "one scientist passing the baton to another." According to Chinese Wikipedia, Tuan was born in 1951※; his research fields were biomedical engineering, stem cells, and tissue engineering, with a focus on the human musculoskeletal system. He earned his doctorate from Rockefeller University in 1977 and, before coming to Hong Kong, served as Director of the Center for Cellular and Molecular Engineering at the University of Pittsburgh School of Medicine.
Tuan took office as the eighth Vice-Chancellor on 1 January 2018, succeeding the seventh Vice-Chancellor, Joseph J.Y. Sung. According to Chinese Wikipedia, he obtained his PhD in Biochemistry and Cell Biology from Rockefeller University in 1977※, undertook postdoctoral research at Harvard Medical School from 1978, and before coming to Hong Kong served as Director of the Center for Cellular and Molecular Engineering at the University of Pittsburgh School of Medicine — an internationally recognised scholar in stem cells and tissue engineering, and, like Lo, a scientist returning from a leading laboratory overseas.
According to Chinese Wikipedia, Tuan was reappointed by the university in 2022※, with his original term extending to the end of 2026; however, he tendered his resignation to the Council on 9 January 2024, stepping down roughly two years early on 7 January 2025, for a term that ran seven years in total. His departure coincided with a period of public discussion over amendments to the CUHK Ordinance and changes to the Council's structure. That one scientist Vice-Chancellor departed before his term was complete, and that another scientist Vice-Chancellor immediately succeeded him by "unanimous approval," are two events that follow one another closely in time, forming the most noteworthy backdrop to this transition.
Different sources emphasise different aspects of the reasons for his resignation; this article sets them side by side without adjudicating between them. As relayed by Chinese Wikipedia, Tuan, in a December 2024 interview with the UK's The Times, said his departure was mainly related to "external interference," and stressed that the university should maintain a "non-politicised" position; the Education Bureau's public response at the time, by contrast, framed the matter in terms of "improving the structure and enhancing governance effectiveness." Extended discussion of university governance and the broader political context falls outside the scope of this article's narrative; readers may consult the external sources in Module 18 on their own.
In terms of academic continuity, the thread connecting the two Vice-Chancellors is clear: Tuan was distinguished in tissue engineering and regenerative medicine, Lo in liquid biopsy and molecular diagnostics; both came from the frontier of translational medicine, and both advocated pushing laboratory findings toward clinical and industrial application. Lo's phrase in his inaugural open letter — continuing "on the foundations laid by his predecessors" — is precisely a continuation of this research-driven line of governance.
Where Does Dennis Lo Want to Take CUHK? — The 2026–30 Blueprint and "Research Reaching Application"
From the outset of his term, Lo placed the weight of his governance on the ground he knows best — research and innovation. According to China Daily, the roadmap he has outlined for his term rests on three pillars: advancing research and innovation, building a talent hub, and strengthening internationalisation※, which will form the cornerstones of CUHK's 2026–2030 strategic plan. The Xinhua interview adds that improving the student experience and promoting alumni and community engagement are also included among the priorities of this five-year blueprint.
"Research reaching application" is the keyword running through it all. In the Xinhua interview, Lo said he believes the present is a "golden period" for innovation and technology in Hong Kong, and argued that researchers should "translate research results into practical application through the combination of industry, academia, and research," treating collaboration between Hong Kong and mainland cities in the Guangdong-Hong Kong-Macao Greater Bay Area as "an important practice of integrating into the nation's overall development." This line of argument is continuous with the conviction he held thirty years earlier that "research must reach application" — only the stage has changed, from a single laboratory to an entire university.
Underpinning this blueprint is a set of quantifiable assets CUHK already holds. According to China Daily, these figures form a pool of resources that "governance by scientist" can draw on immediately; the table below lists several of them (all cumulative figures as reported at the time).
| Indicator | Figure | Basis/point in time |
|---|---|---|
| InnoHK research centres | 7 | Spanning health, biomedicine, robotics, artificial intelligence |
| Patent applications | Over 5,000 | Cumulative since 2014 |
| Patent families | Approx. 1,350 | Cumulative as of the report |
| AI-related startups | 54 | Incubated |
| AI-related degree programmes | 11 | Established |
On top of this resource base, Lo has given Greater Bay Area collaboration a prominent place. According to China Daily, CUHK has already established a School of Artificial Intelligence in Shenzhen, and supports cross-border research through funding mechanisms on both sides — the Shenzhen side provides funding on the order of RMB ten million annually, while the Hong Kong side maintains a matching floor on the order of HKD ten million. Translating "industry-academia-research integration" into concrete institutional arrangements in the Greater Bay Area is what distinguishes this blueprint from an empty slogan.
Internationalisation is the third pillar. According to China Daily, CUHK plans to recruit top faculty and students globally, create new chair professorships and visiting-scholar positions, and extend the college system's coverage to postgraduate students; externally, the university will increase its participation in international university alliances and global academic events, reinforcing its positioning as a "globally integrated university." These three pillars — research and innovation, a talent hub, internationalisation — are not isolated from one another but oriented toward a single goal: letting CUHK's research both "land" in the Greater Bay Area and "stand" on the world stage. For a scientist who changed global obstetric practice with a single paper, this logic is close to a magnified version of his own personal trajectory.
In his method of governance, Lo has also brought a distinct personal stamp. According to media reports, he has proposed "IDEA" to sum up his governing philosophy — Inspire, Discuss, Empower, Achieve; he has stressed that in doing anything, "you must first inspire the people working alongside you," so that the team moves forward with a shared goal and sense of mission. This methodology, drawn from his experience leading laboratory teams, has been transplanted directly into university governance.
Beyond research, Lo has not set aside the line of "nurturing people." In the Xinhua interview, he positioned CUHK as "a comprehensive research university spanning the sciences and humanities," stressed that he "attaches great importance to students' whole-person development," and said CUHK's distinctive college system "creates a diverse, interactive learning environment." In his inaugural open letter, he put the goal for students into a specific phrase — for students to become "servant leaders with a global outlook." A Vice-Chancellor known for hard-edged research placing "whole-person education" and the "college system" alongside innovation and technology is, in a sense, a reaffirmation of CUHK's founding tradition rather than a replacement of it.
Has the Style of Governance Really Changed? — From Administrative Tradition to a "Scientist Brand"
Looking at the two transitions together, the "change" is not found in academic background — both Tuan and Lo are scientists, both from translational medicine; the real difference lies in the paths they took into office and the language of their governance. The table below sets out several verifiable dimensions.
| Dimension | Eighth VC · Rocky S. Tuan | Ninth VC · Dennis Lo |
|---|---|---|
| Took office / stepped down | 1 January 2018 – 7 January 2025 | Took office 8 January 2025, five-year term |
| Academic field | Biomedical engineering, stem cells and tissue engineering | Liquid biopsy, non-invasive prenatal testing, molecular diagnostics |
| Prior role | Director, Center for Cellular and Molecular Engineering, University of Pittsburgh School of Medicine | Joined CUHK in 1997; over 27 years' service at the university |
| Selection atmosphere (per sources) | Resigned and departed early, involving discussion of university governance | Council approval unanimous, with little suspense |
| Governance-language keywords | University should remain "non-politicised" (per his own reported remarks) | "Research reaching application," "industry-academia-research integration," "IDEA" |
One contrast worth noting is "internal seniority." Tuan was a scholar recruited from overseas who took up the Vice-Chancellorship immediately upon arriving in Hong Kong; Lo, by contrast, is an "insider" who spent over 27 years in chemical pathology at CUHK. According to the CUHK-Shenzhen announcement, Lo specifically noted in his inaugural open letter that serving CUHK for 27 years was a source of pride, and summed up the university's mission as, since its founding in 1963, "combining tradition with modernity, and bringing together China and the West"※ — a phrase that only an "insider" would say so naturally.
Only a single day separated the two terms — Tuan stepped down on 7 January, Lo took office on 8 January — and this near-seamless arrangement was itself a statement: the university wanted a smooth transition, not a fresh start. For someone who conducted research for over 27 years in the same medical building at the same university, "succession" reads more like a short walk from the laboratory to the top-floor office than a parachute appointment. This continuity of "insider" status is precisely what CUHK, after the early departure of the previous Vice-Chancellor, appears to have valued in particular.
What "governance by scientist" amounts to, in practice, is layering a scientist's personal research brand and methodology onto university governance: using world-class awards to fill out international prestige, using "research reaching application" to organise the development blueprint, and using the "IDEA" framework from leading a laboratory team to run the administration. Its opportunity lies in the fact that the Vice-Chancellor himself is the university's most persuasive research calling card; its test lies in the fact that governing a comprehensive university requires far more than what is learned in a laboratory. Whether this approach can deliver on the goals of the 2026–30 strategic plan within a five-year term remains, for now, an open question — this article records only the factual thread and the various parties' stated positions surrounding this transition, and offers no prediction.
Sources
- CUHK CPR: Professor Dennis Lo Yuk-ming appointed the ninth Vice-Chancellor and President of CUHK — Official
- CUHK-Shenzhen: Professor Dennis Lo Yuk-ming Officially Assumes Office as the Ninth Vice-Chancellor and President of CUHK — Official
- Xinhua: CUHK appoints Dennis Lo as ninth Vice-Chancellor (2024-09-27) — News
- Xinhua: Cultivating Future Talent with the Light of Science — an interview with CUHK Vice-Chancellor Dennis Lo (2025-04-25) — News
- China Daily HK: CUHK chief prioritizes talent, innovation, global reach — News
- Tencent News: Nearly ten million pregnant women benefit from this technology each year (on Dennis Lo's Lasker Award) — News
- Dennis Lo (English Wikipedia) — Secondary
- Rocky S. Tuan (Chinese Wikipedia) — Secondary
Sources · verify independently
- OfficialCUHK CPR:Professor Dennis Lo Yuk-ming appointed the ninth Vice-Chancellor and President of CUHK
- OfficialCUHK-Shenzhen:Professor Dennis Lo Yuk-ming Officially Assumes Office as the Ninth Vice-Chancellor and President of CUHK
- News新华网:香港中文大学任命卢煜明为第九任校长
- News新华网:以科学之光培育未来之才——访香港中文大学校长卢煜明
- NewsChina Daily HK:CUHK chief prioritizes talent, innovation, global reach
- News腾讯新闻:每年近千万名孕妇因这项技术受惠(卢煜明拉斯克奖)
- SecondaryDennis Lo(英文维基百科)
- Secondary段崇智(中文维基百科)